Pharmaceutical composition for preventing or treating atopic dermatitis comprising clonal stem cells
KR20200111640A
Treating method for treating atopic dermatitis using mono clonal stem cell and using thereof
WO2020149538A1
Pharmaceutical composition comprising clonal stem cell for prevention or treatment of atopic dermatitis
WO2020130431A1
Pharmaceutical composition comprising clonal stem cells for treating graft-versus-host disease
WO2020122498A1
Pharmaceutical composition for treating pancreatitis, comprising clonal stem cells
KR20190059886A
The method for isolation of stem cells from bone marrow using subfractionation culturing method and proliferation thereof
KR20200127455A
A cosmetic composition comprising a culture medium of mesenchymal stem cells cultured in a hPL containing medium
US2018289772A1
Pharmaceutical composition for preventing or treating hair loss comprising chemokine (C-X-C motif) ligand 1 (CXCL1) protein or CXCL1 protein and minoxidil as active ingredient
KR20190051362A
The method for isolation of stem cells from bone marrow using subfractionation culturing method and proliferation thereof
KR20190016283A
Pharmaceutical composition for preventing or treating hair loss comprising CXCL1 protein and minoxidil
WO2017146538A1
Pharmaceutical composition for preventing or treating regulatory t cell-mediated diseases
KR101816246B1
Pharmaceutical composition for prevention or treatment of immune diseases and inflammatory diseases comprising immunogenic stimulated mesenchymal stem cells
KR101657082B1
Pharmaceutical composition for preventing or treating hair loss comprising CXCL1 protein
KR101671361B1
Pharmaceutical composition for preventing or treating hair loss comprising TYMP(thymidine phosphorylase) protein
KR20170014270A
Isolation of adipose-derived stem cells by using a subfractionation culturing method
